Latest Schedule 13G passive stakes

Skandinaviska Enskilda Banken AB (publ) has filed a Schedule 13G, disclosing beneficial ownership of 5.3% of Autoliv Inc.'s common stock represented by Swedish Depositary Receipts.

Armistice Capital, LLC and Steven Boyd report beneficial ownership of 3,264,000 shares, representing 8.01% of Orthofix Medical Inc.'s common stock.

Armistice Capital, LLC and Steven Boyd have updated their beneficial ownership filing for Nuwellis, Inc., reporting a 4.99% stake.

Armistice Capital, LLC, along with its managing member Steven Boyd, has reported beneficial ownership of 7.88% of MacroGenics, Inc. common stock as of June 30, 2026.

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 3,372,000 shares, representing 7.57% of Li-Cycle Holdings Corp.'s common stock.

Ameriprise Financial, Inc. and its subsidiary Columbia Management Investment Advisers, LLC have filed an amendment to their Schedule 13G, reporting changes in their beneficial ownership of Tripadvisor, Inc. common stock.

Ameriprise Financial, Inc. and its subsidiary Columbia Management Investment Advisers, LLC have filed an amendment to their Schedule 13G, reporting changes in their beneficial ownership of Tripadvisor, Inc. common stock.

Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, disclosing beneficial ownership of 9.88% of Kyntra Bio, Inc.'s common stock.

Armistice Capital, LLC and Steven Boyd have filed a Schedule 13G, reporting beneficial ownership of 120,537 shares of INVO FERTILITY, INC. common stock, representing 4.99% of the class.

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 13,932,000 shares, representing 8.43% of Ironwood Pharmaceuticals, Inc.'s Class A common stock.

Armistice Capital, LLC, along with its managing member Steven Boyd, has reported beneficial ownership of 9.99% of Inuvo, Inc.'s common stock as of June 30, 2026.

Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 141,397 shares, representing 5.91% of Intelligent Bio Solutions Inc.'s common stock.

Aristeia Capital, L.L.C. has disclosed a beneficial ownership of 900,000 units, representing 5.22% of the outstanding shares in JAB Acquisition Corp I.

Armistice Capital, LLC and Steven Boyd have filed a Schedule 13G, reporting beneficial ownership of 450,315 shares, representing 9.99% of Imunon, Inc.'s common stock.

Aristeia Capital, L.L.C. has disclosed beneficial ownership of 5.24% of Maywood Acquisition Corp.'s Class A Ordinary Shares.

Armistice Capital, LLC and Steven Boyd have jointly reported beneficial ownership of 300,332 ordinary shares, representing 9.99% of IceCure Medical Ltd., as of June 30, 2026.

Eric M. Mindich has updated his beneficial ownership in Blue Moon Metals Inc. to 3.5% as of June 30, 2026, based on the latest outstanding share count.

Aristeia Capital, L.L.C. has reported beneficial ownership of 1,315,573 Class A ordinary shares, representing 5.20% of the outstanding shares of Inflection Point Acquisition Corp. VI.

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 387,038 shares, representing 4.99% of GeoVax Labs, Inc. common stock.

Ameriprise Financial and Columbia Management report a combined 6.3% beneficial ownership of Diversified Energy Company common stock.

Ameriprise Financial and Columbia Management report a combined 6.3% beneficial ownership of Diversified Energy Company common stock.

Armistice Capital, LLC and Steven Boyd have jointly reported beneficial ownership of 9.99% of Global Interactive Technologies, Inc. common stock.

Aristeia Capital, L.L.C. has filed a Schedule 13G, reporting beneficial ownership of 4,840,477 shares of Hadron Energy, Inc. common stock, representing 6.59% of the outstanding shares.

Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 9.99% of Generation Income Properties, Inc. common stock as of June 30, 2026.

Aristeia Capital, L.L.C. has filed a Schedule 13G, disclosing beneficial ownership of 2,203,396 warrants in OppFi Inc., representing 2.52% of the class.

Aristeia Capital, L.L.C. has filed a Schedule 13G, revealing beneficial ownership of 652,725 units in FortuneX Acquisition Corporation, representing approximately 7.55% of the outstanding securities.

Armistice Capital, LLC and Steven Boyd report acquiring a 9.99% beneficial ownership in FibroBiologics, Inc. common stock.

Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 713,539 ordinary shares, representing 4.99% of Evogene Ltd.'s outstanding shares.

Aristeia Capital, L.L.C. has disclosed beneficial ownership of 1,350,000 units, representing 5.30% of Praetorian Acquisition Corp.'s outstanding shares as of June 30, 2026.

Aristeia Capital, L.L.C. has disclosed a beneficial ownership of 2,178,000 units, representing 8.61% of the outstanding shares of Collective Acquisition Corp. II.